Technologies that could offer a step change in treatment or management of incontinence were the focus of the latest symposium, run by the IMPRESS network.
A new technique to help ensure the bowel heals properly following cancer surgery is to be assessed in an international clinical trial, with support from the HTC.
The Colorectal Therapies HTC is working in partnership with environmental packaging company, Valueform, to extend and enlarge their medical product range.
A new clinical technology to improve detection of cancerous polyps during colonoscopy is being investigated, with support from the Colorectal Therapies HTC.
The HTC has been selected by the Health Foundation, an independent health care charity, to be part of its £1.5 million innovation programme, Innovating for Improvement.
New technologies that could improve the lives of people with faecal incontinence were discussed in a workshop run by the IMPRESS (Incontinence Management and Prevention through Engineering and Sciences) network in February.
The HTC has strengthened its management team with the appointment of Dr Randolph Haggerty as project manager.
Interactive workshops are being held this month to take forward the biotechnology concept chosen by the HTC Foundation ‘Dragon’s Den’ in December.
This year, a clear message emerged from our National Meeting: to successfully develop and commercialise a technology, you need to engage with the right people at the right time.
Five new technologies for treating or managing incontinence have been awarded proof of concept funding by IMPRESS (Incontinence Management and Prevention through Engineering and Science).